After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Alnylam Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Alnylam Pharmaceuticals Inc is $32.97B. A total of 0.99 million shares were traded on the day, compared to an average of 692.71K shares.
In the most recent transaction, Fitzgerald Kevin Joseph sold 1,911 shares of ALNY for 243.73 per share on Mar 03 ’25. After the transaction, the CSO & EVP, Head of Research now owns 14,345 company shares. In a previous transaction on Mar 04 ’25, Fitzgerald Kevin Joseph sold 844 shares at 241.15 per share. ALNY shares that CSO & EVP, Head of Research owns now total 13,501.
Among the insiders who sold shares, Tanguler Tolga disposed of 471 shares on Mar 03 ’25 at a per-share price of $243.78. This resulted in the EVP, Chief Commercial Officer holding 28,011 shares of ALNY after the transaction. In another insider transaction, Garg Pushkal sold 1,749 shares at $243.79 per share on Mar 03 ’25. Company shares held by the CMO & EVP Dev & Med Affairs now total 25,350.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ALNY has a high of $304.39 and a low of $141.98.
As of this writing, ALNY has an earnings estimate of -$0.42 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of $0.39 per share and a lower estimate of -$0.93.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ALNY’s latest balance sheet shows that the firm has $2.44B in Cash & Short Term Investments as of fiscal 2021. There were $997.59M in debt and $695.71M in liabilities at the time. Its Book Value Per Share was $0.52, while its Total Shareholder’s Equity was $588.20M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ALNY is Buy with a score of 4.25.
